Biotech

All Articles

AstraZeneca pays out CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has actually paid off CSPC Pharmaceutical Group $100 million for a preclinical heart di...

Zephyrm seeks Hong Kong IPO to finance period 3 tissue treatment tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, filing (PDF) for an IPO to bank...

Frazier Life Sciences gets $630M for little, mid-cap biotechs

.Frazier Lifespan Sciences has sourced a better $630 million for its own fund concentrated on small ...

GigaGen gets around $135M BARDA dollars to hammer botox

.Antitoxin connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its own tec...

GPCR agency Septerna apply for IPO on toughness of preclinical data

.Septerna will figure out exactly how a biotech without "any kind of purposeful medical information"...

Kurma finalizes first $154M payload for greatest biotech fund yet

.International VC agency Kurma Partners has introduced its own most current biotech fund, with 140 m...

Prothena advertises one exec while another keeps-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of significant management hirings, firings ...

Editas profit Tip Cas9 licensing civil rights for $57M

.Against the background of a Cas9 patent struggle that declines to die, Editas Medicine is moneying ...

Ultragenyx tweaks gene therapy application to call up efficacy

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson condition gene treatment UX701 hav...

Biopharma unemployment rate supports in Q3: Brutal Biotech analysis

.As summer season warmth looks to cool down winds, hopes that this year would certainly deliver comm...